Abstract
Angiogenic cytokines constitute a potentially novel form of therapy for patients with cardiovascular disease. The feasibility of using recombinant formulations of angiogenic growth factors to expedite and/or augment collateral artery development in animal models of myocardial and hindlimb ischemia — “therapeutic angiogenesis” — has now been well established. These studies have suggested that two angiogenic growth factors in particular, basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), are sufficiently potent to merit further investigation. More recently, experiments performed in our laboratory have indicated that in the case of VEGF, a secreted protein, similar results may be achieved by percutaneous arterial gene transfer. Further laboratory and clinical studies may yield promising insights into the fundamental basis for native as well as therapeutic angiogenesis, and at the same time more explicitly define the manner in which therapeutic angiogenesis may be successfully incorporated into clinical practice.
Keywords
- Vascular Endothelial Growth Factor
- Basic Fibroblast Growth Factor
- Ischemic Limb
- Angiogenic Growth Factor
- Therapeutic Angiogenesis
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285:1182–1186
Shing Y, Folkman J, Sullivan J, Butterfield R, Murray J, Klagsbrun M: Heparin-afinity purification of a tumor-derived capillary endothelial cell growth factor. Science 1984; 223:1296–1299
Folkman J, Shing Y: Angiogenesis J Biol Chem 1992; 267:10931–10934
Hockel M, Schlenger K, Doctrow S, Kissel T, Vaupel P: Therapeutic angiogenesis. Arch Surg 1993; 128:423–429
Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P: Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Sur 1992; 16:181–191
Pu LQ, Sniderman AD, Brassard R, et al.: Enhanced revascularization of the ischémic limb by means of angiogenic therapy. Circulation 1993; 88:208–215
Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al.: Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992; 257:1401–1403
Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161:851–855
Keck PJ, Hauser SD, Krivi G, et al.: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246:1309–1342
Connolly DR, Olander JV, Heuvelman D, et al.: Human vascular permeability factor: isolation from U937 cells. J Biol Chem 1989; 264:20017–20024
Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246:1306–1309
de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The/mi-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255:989–991
Millauer B, Wizigmann-Voos S, Schnurch H, et al.: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72:835–846
Terman BI, Dougher-Vermozen M, Carrion ME, et al.: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor. Biochem Biophys Res Commun 1992; 187:1579–1586
Klagsbrun M, D’Amore PA: Regulators of angiogenesis. Annu Rev Physiol 1991; 53:217–239
Reidy MA, Clowes AW, Schwartz SM: Endothelial regeneration V. inhibition of endothelial regrowth in arteries of rat and rabbit. Lab Invest 1983; 49:569–575
Conn G, Soderman D, Schaeffer M-T, Wile M, Hatcher VB, Thomas KA: Purification of glycoprotein vascular endothelial cell mitogen from a rat glioma cell line. Proc Natl Acad Sci USA 1990; 87:1323–1327
Shen H, Clauss M, Ryan J, et al.: Characterization of vascular permeability factor / vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 1993; 81:2767–2773
Clauss M, Gerlach M, Gerlach H, et al.: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990; 172:1535–1545
Levy AP, Tamargo R, Brem H, Nathans D: An endothelial cell growth factor from the mouse neuroblastoma cell line NB41. Growth Factors 1989; 2:9–19
Connolly DT, Hewelman DM, Nelson R, et al.: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84:1470–1478
Takeshita S, Zheng LP, Brogi E, et al.: Therapeutic angiogenesis: A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischémic hind limb model. J Clin Invest 1994; 93:662–670
Takeshita S, Pu LQ, Stein LA, et al.: Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 1994; 90[Part 2]:II–228–II–234
Bauters C, Asahara T, Zheng LP, et al.: Site-specific therapeutic angiogenesis following systemic administration of vascular endothelial growth factor. J Vasc Surg 1995; 21:314–325
Bauters C, Asahara T, Zheng LP, et al.: Physiologic assessment of augmented vascularity induced by VEGF in rabbit ischemie hindlimb. Am J Physiol 1994; 36:H1263–H1271
Sellke FW, Quillen JE, Brooks LA, Harrison DG: Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation 1990; 81:1938–1947
Sellke FW, Wang SY, Friedman M, et al.: Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am J Physiol 1994;267(2):H1303–1311.
Bauters C, Asahara T, Zheng LP, et al.: Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischémie hindlimb following administration of vascular endothelial growth factor. Circulation 1995; 91:2801–2809
Losordo DW, Pickering JG, Takeshita S, et al: Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo: Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation 1994; 89:785–792
Riessen R, Rahimizadeh H, Blessing E, Takeshita S, Barry JJ, Isner JM: Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther 1993; 4:749–758
Takeshita S, Weir L, Zheng LP, et al.: Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Proc Natl Acad Sci USA (In Press)
Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW: The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991; 47:211–218
D’Amore PA, Thompson RW: Mechanisms of angiogenesis. Anm Rev Physiol 1987; 49:453–464
Senger DR, Perruzzi CA, Feder J, Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Canc Res 1986; 46:5629–5632
Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219:983–985
Dvorak HF, Sioussat TM, Brown LF, et al.: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Expt Med 1991; 174:1275–1278
Schaper W: Coronary collateral development: concepts and hypothesis. In: Collateral Circulation: Heart, Brain, Kidney, Limbs, edited by Schaper W and Schaper J. Boston: Kluwer Academic Publishers, 1993, p. 41–64.
Sholley MM, Ferguson GP, Seibel HR, Montour JL, Wilson JD: Mechanisms of neovascularization: Vascular sprouting can occur without proliferation of endothelial cells. Lab Invest 1984; 51:624–634
Nicosia RF, Bonanno E, Smith M: Fibronectin promotes the elongation of microvessels during angiogenesis in vitro. J Cell Physiol 1993; 154:654–661
Schaper J, Weibrauch D: Collateral vessel development in the porcine and canine heart. In: Collateral circulation: heart, brain, kidney, limbs, edited by Schaper W and Schaper J. Norwell, MA: Kluwer Academic Publishers, 1993, p. 65–102.
Schaper W, de Brabander M, Lewi P: DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res 1971; 28:671–679
Pasyk S, Schaper W, Schaper J, Pasyk K, Miskiewicz G, Steinseifer B: DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog. Am J Physiol 1982; 242:H1031–H1037
Cowan DF, Hollenberg NK, Connelly CM, Williams DH, Abrams HL: Increased collateral arterial and venous endothelial cell turnover after renal artery stenosis in the dog. Invest Radiol 1978; 13:143–149
Ilich N, Hollenberg NK, Williams DH, Abrams H: Time course of increased collateral arterial and venous endothelial cell turnover after renal artery stenosis in rat. Circ Res 1979; 45:579-532
White FC, Carroll SM, Magnet A, Bloor CM: Coronary collateral development in swine after coronary artery occlusion. Circ Res 1992; 71:1490–1500
Schaper W, Schaper J, Xhonneux R, Vandesteene R: The morphology of intercoronary anastomoses in chronic coronary artery occlusion. Cardiovasc Res 1969; 3:315–323
Graham AM, Baffour R, Burdon T, et al.: A demonstration of vascular proliferation in response to arteriovenous reversal in the ischemie canine hind limb. J Surg Res 1989; 47:341–347
Symes JF, Graham AM, Stein L, Sniderman AD: Salvage of a severely ischemic limb by arteriovenous revascularization: a case report. Can J Surg 1984; 27:274–276
Unger EF, Banai S, Shou M, et al.: Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 1994; 266:H1588–H1595
Takeshita S, Rossow ST, Kearney M, et al.: Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol 1995;147(6):1649–1660.
Dvorak HF: Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986; 315:1650–1659
Herbert JM, Lamarche I, Prabonnaud V, Dol F, Gauthier T: Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J Biol Chem 1994; 269:3076–3080
Pepper MS, Ferrara N, Orci L, Montesano R: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor type 1 in microvascular endothelial cells. Biochem Biophys Res Commun 1994; 189:824–831
Ross R, Glomset B, Kariya B, Harker L: A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 1974; 71:1207–1210
Collins T, Ginsburg D, Boss JM, Orkin SH, Pober JS: Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structual analysis. Nature 1985; 316:748–750
Collins T, Pober JS, Gimbrone MA Jr, Betsholtz C, Westermark B, Heldin C-H: Cultured human endothelial cells express platelet-derived factor A chain. Am J Pathol 1987; 126:7–12
Zerwes H-G, Risau W: Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro. J Cell Biol 1987; 105:2037–2041
Gay CG, Winkles JA: Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression. J Biol Chem 1990; 265:3284–3292
Roberts AB, Sporn MB, Assoian RK, et al.: Transforming growth factor type-beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986; 83:4167–4171
Risau W, Drexler H, Mironov V, et al.: Platelet-derived growth factor is angiogenic in vivo. Growth Factors 1992; 7:261–266
Lindner V, Lappi DA, Baird RA, Majack RA, Reidy, MA: Role of basic fibroblast growth factor in vascular lesion formation. CircRes 1991; 68:106–113
Lindner V, Reidy MA: Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. Circ Res 1993; 73:589–595
Beitz JG, Kim IS, Calabresi P, Frackelton AR: Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci USA 1991; 88:2021–2025
Smite A, Hermansson M, Nister M, Kamushina I, Heldin C-H, Oberg K: Rat brain capillary endothelial cells express functional PDGF B-type receptors. Growth Factors 1989; 2:1–8
Bar RS, Boes M, Booth BA, Dake BL, Henley S, Hart MN: The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology 1989; 124:2021–2025
D’Amore P, Smith SR: Growth factor effects on cells of the vascular wall: a survey. Growth Factors 1993; 8:61–75
Pierce GF, Tarpley JE, Yanagihara D, Mustoe TE, Fox GM, Thomason A: Platelet derived growth factor (BB homodimer), transforming growth factor-betal, and basic fibroblast growth factor in dermal wound healing. Am J Pathol 1992; 140:1375–1388
Sims DE: The pericyte-a review. Tissue Cell 1986; 18:153–174
Sundberg C, Ljungstrom M, Lindmark G, Gerdin B, Rubin K: Microvascular pericytes express platelet-derived growth factor-b receptors in human healing wounds and colorectal adenocarcinoma. Am J Pathol 1993; 143:1377–1388
Sato N, Beitz JG, Kato J, et al.: Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 1993; 142:1119–1139
Brogi E, Wu T, Namiki A, Isner JM: Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994; 90:649–652
Pepper MS, Vassalli JD, Orci L, Montesano R: Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp Cell Res 1993; 204:356–363
Chen JK, Hoshi H, McKeehan WL: Transforming growth factor type b specifically stimulates synthesis of proteoglycans in human adult arterial smooth muscle cells. Proc Natl Acad Sci USA 1987; 84:5287–5291
Madri JA, Pratt BM, Tucker AM: Phenotypic modulation of endothelial cells by transforming growth factor-b depends upon the composition and organization of the extracellular matrix. J Cell Biol 1993; 106:1375–1384
Winkles JA, Gay CG: Serum, phorbol ester, and polypeptide mitogens increase class 1 and 2 Heparin binding (acidic and basic fibroblast growth factor) gene expression in human vascular smooth muscle cells. Cell Growth & Differ 1991; 2:531–540
Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Science 1992; 359:843–845
Tischer E, Mitchell R, Hartman T, et al.: The human gene for vascular endothelial growth factor. J Biol Chem 1991; 266:11947–11954
Wang GL, Semenza GL: Characterization of hypoxia-inducible factor I and regulation of DNA binding activity by hypoxia. Blood 1993; 268:21513–21518
Goto F, Goto K, Weindel K, Folkman J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993; 69:508–517
Asahara T, Bauters C, Pastore CJ, et al.: Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon-injured rat carotid artery. Circulation 1995;1;91(11):2793–2801
Asahara T, Bauters C, Pastore CJ et al.: Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 1995; 91:2793–2801
Klagsbrun M, Folkman J: Angiogenesis. In: Peptide Growth Factors and Their Receptors II, edited by Sporn MB and Roberts AB New York: Springer-Verlag, 1990, p. 459–586.
Asahara T, Bauters C, Zheng LP, et al.: Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.Circulation 1995;1;92(9 Suppl).II365–371.
Wilting J, Christ B, Bokeloh M, Weich HA: In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell TissueRes 1993; 68:106–113
Klagsbrun M, Baird A: A duel receptor system is required for basic fibroblast growth factor activity. Cell 1991; 67:229–231
Park JE, Chen HH, Winer J, Houck KA, Ferrara N: Placenta growth factor: potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994; 269:25646–25654
Isner JM, Walsh K, Symes J, et al.: Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 1995; 91:2687–2692
Fisher M, Meadows ME, Do T, et al.: Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. J Cereb Blood Flow Metab 1995;15(6):953–959.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Isner, J.M. (1997). Angiogenesis and Collateral Formation. In: March, K.L. (eds) Gene Transfer in the Cardiovascular System. Developments in Cardiovascular Medicine, vol 189. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6277-1_14
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6277-1_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7881-5
Online ISBN: 978-1-4615-6277-1
eBook Packages: Springer Book Archive